Fig. 3From: A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort studyOverall survival. AÂ Based on HIV overall survival rate. BÂ Based on CD4/FIB-4 overall survival rateBack to article page